| Stage | EXEL | % of rev | AMGN | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $629M | 100.00% | $10.1B | 100.00% | AMGN ×15.99 |
| Gross profit | $608M | 96.71% | $7.2B | 72.04% | EXEL +24.7pp |
| Operating income | $248M | 39.51% | $3.5B | 34.95% | EXEL +4.6pp |
| Pre-tax income | $263M | 41.78% | $2.8B | 27.53% | EXEL +14.3pp |
| Net income | $212M | 33.73% | $2.4B | 23.62% | EXEL +10.1pp |
| Stage | EXEL | AMGN | Gap · A − B |
|---|---|---|---|
| Revenue | $629M100.00% | $10.1B100.00% | AMGN ×15.99 |
| Gross profit | 96.71%$608M | 72.04%$7.2B | EXEL +24.7pp |
| Operating income | 39.51%$248M | 34.95%$3.5B | EXEL +4.6pp |
| Pre-tax income | 41.78%$263M | 27.53%$2.8B | EXEL +14.3pp |
| Net income |
| 33.73%$212M |
| 23.62%$2.4B |
| EXEL +10.1pp |
No shared counterparties.